Literature DB >> 23644100

Temporal and spatial pattern of RhoA expression in injured spinal cord of adult mice.

Xiaoning Kang1, Jingkun Wen, Xianghai Wang, Mengjie Pan, Weiwei Zhang, Xiaoduo Zhan, Zhongying Liu, Wutian Wu, Jiasong Guo.   

Abstract

OBJECTIVE: To quantitatively analyze the temporal and spatial pattern of RhoA expression in injured spinal cord of adult mice.
METHODS: A spinal cord transection model was established in adult mice. At 1, 3, 7, 14, 28, 56 and 112 days after the surgery, the spinal cords were dissected and cryosectioned for RhoA/NF200, RhoA/GFAP, RhoA/CNPase or RhoA/IBA1 double fluorescent immunohistochemistry to visualize RhoA expressions in the neurons, astrocytes, oligodendrocytes and microglia. The percentages as well as the immunostaining intensities of RhoA-positive cells in the parenchymal cells were quantitatively analyzed.
RESULTS: RhoA was weakly expressed in a few neurons and oligodendrocytes in normal spinal cord. After spinal cord injury, the percentage of RhoA-positive cells and RhoA expression intensity in the spinal cord increased and peaked at 7 days post injury (dpi) in neurons, oligodendrocytes and astrocytes, followed by a gradual decrease till reaching a low level at 112 dpi. In the microglia, both the RhoA-positive cells and RhoA expression intensity reached the maximum at 14 dpi and maintained a high level till 112 dpi.
CONCLUSION: Traumatic spinal cord injury can upregulate RhoA expression in the neurons as well as all the glial cells in the spinal cord. RhoA expression patterns vary with post-injury time, location and among different parenchymal cells in the injured spinal cord.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23644100

Source DB:  PubMed          Journal:  Nan Fang Yi Ke Da Xue Xue Bao        ISSN: 1673-4254


  1 in total

1.  Topical administration of a Rock/Net inhibitor promotes retinal ganglion cell survival and axon regeneration after optic nerve injury.

Authors:  Peter X Shaw; Alan Sang; Yan Wang; Daisy Ho; Christopher Douglas; Lara Dia; Jeffrey L Goldberg
Journal:  Exp Eye Res       Date:  2016-07-18       Impact factor: 3.467

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.